View Author
prostate patient biopsy cancer prostate cancer study imaging gleason mr-gb trusbx obesity prostatectomy tumour cohort performance grade body mass index undergrading radboud university nijmegen 10- score urology aggressiveness performance rates 10- core trusbx signi value university analysis resonance result tumours weight gleason grades recurrence table nijmegen region diffusion european factor resonance imaging centre diffusion coef ficient prevalence volume diffusion-weighted imaging difference range population netherland assessment health transrectal follow-up hambrock pretreatment assessment stage diffusion-weighted index signi ficantly radboud gleason grade month prognostic prostate-speci fic antigen pathology margin –guided needle 2-weighted therapy prostate needle biopsy pretreatment group prognostic marker number pca aggressiveness 177–184 multivariable
2 Most Recent Publications
|
Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort
(Article)
Hambrock, T. Hoeks, C. Hulsbergen-Van de Kaa, C.A. Scheenen, T. Fütterer, J. Bouwense, S. Oort, I.M. van Schröder, F.H. Huisman, H. Barentsz, J. |
2012-01-01
|
|
Body mass index as a prognostic marker for biochemical recurrence in dutch men treated with radical prostatectomy
(Article)
Roermund, J.G.H. van Kok, D.E.G. Witjes, J.A. Wildhagen, M.F. Kiemeney, L.A.L.M. Struik, F. Sloot, S. Oort, I.M. van Hulsbergen-Van de Kaa, C.A. Leenders, G.J. van Bangma, C.H. |
2009-08-01
|
